期刊的影响因子--文章列表

期刊文章列表
Lingling Zhang^1,2，Kuan Hu³，Tuo Shao⁴，Lu Hou¹，Shaojuan Zhang¹，Weijian Ye¹，Lee Josephson⁴，Jeffrey H.Meyer⁵，Ming-Rong Zhang³，Neil Vasdev^4,5，Jinghao Wang⁶，Hao Xu¹，Lu Wang^1,4，Steven H.Liang⁴（Center of Cyclotron and PET Radiopharmaceuticals，Department of Nuclear Medicine and PET/CT-MRI Center，The First Affiliated Hospital of Jinan University；Department of Neurology，the First Affiliated Hospital of Jinan University；Department of Radiopharmaceuticals Development，National Institute of Radiological Sciences，National Institutes for Quantum and Radiological Science and Technology；Division of Nuclear Medicine and Molecular Imaging，Massachusetts General Hospital & Department of Radiology，Harvard Medical School；Azrieli Centre for Neuro-Radiochemistry，Brain Health Imaging Centre，Centre for Addiction and Mental Health &Department of Psychiatry，University of Toronto；Department of Pharmacy，the First Affiliated Hospital of Jinan University）.Recent developments on PET radiotracers for TSPO and their applications in neuroimaging[J].Acta Pharmaceutica Sinica B,2021,第2期 Tingting Jiang¹，Guan Wang¹，Yao Liu¹，Lu Feng¹，Meng Wang¹，Jie Liu¹，Yi Chen²，Liang Ouyang¹（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，and Collaborative Innovation Center of Biotherapy，Sichuan University；State Key Laboratory of Biotherapy and Cancer Center and Department of Gastrointestinal Surgery，West China Hospital，Sichuan University，and Collaborative Innovation Center for Biotherapy）.Development of small-molecule tropomyosin receptor kinase(TRK) inhibitors for NTRK fusion cancers[J].Acta Pharmaceutica Sinica B,2021,第2期 Kaiyue Yu，Xiuming Yu，Sisi Cao，Yixuan Wang，Yuanhao Zhai，Fengdie Yang，Xiaoyuan Yang，Yi Lu，Chuanbin Wu，Yuehong Xu（School of Pharmaceutical Sciences，Sun Yat-sen University）.Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis[J].Acta Pharmaceutica Sinica B,2021,第2期 Zhiming Zhangy，Chenlu Huangy，Li Zhang，Qing Guo，Yu Qin，Fan Fan，Boxuan Li，Bao Xiao，Dunwan Zhu，Linhua Zhang（Tianjin Key Laboratory of Biomedical Materials，Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences & Peking Union Medical College）.pH-sensitive and bubble-generating mesoporous silica-based nanoparticles for enhanced tumor combination therapy[J].Acta Pharmaceutica Sinica B,2021,第2期 Hao Cai¹，Yufan Xiang¹，Yujun Zeng¹，Zhiqian Li¹，Xiuli Zheng¹，Qiang Luo¹，Hongyan Zhu²，Qiyong Gong¹，Zhongwei Gu¹，Yanhui Liu¹，Hu Zhang³，Kui Luo¹（Huaxi MR Research Center(HMRRC)，Department of Neurosurgery，and Department of Radiology，Functional and Molecular Imaging Key Laboratory of Sichuan Province，West China Hospital，Sichuan University；Laboratory of Stem Cell Biology，West China Hospital，Sichuan University；Amgen Bioprocessing Centre，Keck Graduate Institute）.Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment[J].Acta Pharmaceutica Sinica B,2021,第2期 Shaojun Peng^1,2，Boshu Ouyang³，Yongjie Xin¹，Wei Zhao¹，Shun Shen⁴，Meixiao Zhan¹，Ligong Lu¹（Zhuhai Precision Medical Center，Zhuhai Interventional Medical Center，Zhuhai People’s Hospital(Zhuhai Hospital Affiliated with Jinan University)；The Institute for Translational Nanomedicine，Shanghai East Hospital，Tongji University School of Medicine；Central Laboratory，First Affiliated Hospital，Institute of Integrative Medicine，Dalian Medical University；Zhejiang Cancer Hospital，Institute (College) of Cancer Research）.Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery[J].Acta Pharmaceutica Sinica B,2021,第2期 Jianfeng Wang¹，Xiaomao Yin¹，Wei He²，Wei Xue¹，Jin Zhang¹，Yiran Huang¹（Department of Urology，Renji Hospital，School of Medicine，Shanghai Jiao Tong University；Department of Pathology，Renji Hospital，School of Medicine，Shanghai Jiao Tong University）.SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis[J].Acta Pharmaceutica Sinica B,2021,第2期 Qian Wei¹，Jian Bai¹，Daojiang Yan¹，Xiuqi Bao¹，Wenting Li²，Bingyu Liu¹，Dan Zhang¹，Xiangbing Qi²，Dequan Yu¹，Youcai Hu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Institute of Biological Sciences）.Genome mining combined metabolic shunting and OSMAC strategy of an endophytic fungus leads to the production of diverse natural products[J].Acta Pharmaceutica Sinica B,2021,第2期 Xu Jing^1,2，Dandan Ren^1,3，Fei Gao²，Ye Chen¹，Xiao Wu⁴，Yue Han¹，Qingsheng Han¹，Liang Li¹，Xiaojie Wang¹，Wei Tang⁵，Yan Zhang¹（Department of Pharmacology，School of Basic Medical Science，Shandong University；Department of Clinical Laboratory，the Second Hospital of Shandong University；Chengda Biology Co.，Ltd.；The Key Laboratory of Cardiovascular Remodeling and Function Research，Department of Cardiology，Qilu Hospital of Shandong University；Department of Microbiology，School of Basic Medical Science，Shandong University）.Gene deficiency or pharmacological inhibition of PDCD4-mediated FGR signaling protects against acute kidney injury[J].Acta Pharmaceutica Sinica B,2021,第2期 Yifan Chen，Xuejing Shao，Ji Cao，Hong Zhu，Bo Yang，Qiaojun He，Meidan Ying（Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University）.Phosphorylation regulates cullin-based ubiquitination in tumorigenesis[J].Acta Pharmaceutica Sinica B,2021,第2期 Dominik Bakalarz^1,2，Marcin Surmiak^1,3，Xiaoxiao Yang⁴，Dagmara Wójcik¹，Edyta Korbut¹，Zbigniew ?liwowski¹，Grzegorz Ginter¹，Grzegorz Buszewicz⁵，Tomasz Brzozowski¹，Jakub Cieszkowskia¹，Urszula G?owacka¹，Katarzyna Magierowska¹，Zhixiang Pan⁴，Binghe Wang⁴，Marcin Magierowski¹（Department of Physiology，Jagiellonian University Medical College；Department of Forensic Toxicology，Institute of Forensic Research；Department of Internal Medicine，Jagiellonian University Medical College；Department of Chemistry and Center for Diagnostics and Therapeutics，Georgia State University；Department of Forensic Medicine，Medical University of Lublin）.Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage[J].Acta Pharmaceutica Sinica B,2021,第2期 Xiaohua Liu^1,2,3，Yu Zhang⁴，Yalei Li⁵，Juan Wang⁴，Huaqian Ding^1,3，Wenjing Huang⁴，Chunyong Ding^1,2，Hongchun Liu⁵，Wenfu Tan⁴，Ao Zhang^1,2,6,3,7（CAS Key Laboratory of Receptor Research，Shanghai Institute of Materia Medica (SIMM)，Chinese Academy of Sciences；School of Pharmacy，Shanghai Jiao Tong University；University of Chinese Academy of Sciences；Department of Pharmacology，School of Pharmacy，Fudan University；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica (SIMM)，Chinese Academy of Sciences；School of Life Science and Technology，Shanghai Tech University；State Key Laboratory of Esophageal Cancer Prevention and Treatment，Ministry of Education of China，Zhengzhou University）.Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma[J].Acta Pharmaceutica Sinica B,2021,第2期 Yunkai Yang¹，Xiaohan Guo¹，Bo Hu²，Peng He¹，Xiaowu Jiang³，Zuohuan Wang⁴，Huaxing Zhu²，Lina Hu⁵，Minghua Yu⁵，Meiqing Feng¹（Shanghai Engineering Research Center of Immuno Therapeutics，School of Pharmacy，Fudan University；Shanghai Novoprotein Biotechnology Co.，Ltd.；Medical School of Yichun University；Clinical Research Center，2nd Affiliated Hospital，Medical College of Zhejiang University；Department of Oncology，Shanghai Pudong Hospital，Fudan University Pudong Medicine Center）.Generated SecPen＿NY-ESO-1＿ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses[J].Acta Pharmaceutica Sinica B,2021,第2期 Pengzhao Shang¹，Rui Gao¹，Yijia Zhu¹，Xiaorui Zhang¹，Yang Wang¹，Minji Guo¹，Hui Peng²，Min Wang¹，Juan Zhang¹（Antibody Engineering Laboratory，School of Life Science & Technology，China Pharmaceutical University；Department of Operational Medicine，Tianjin Institute of Environmental & Operational Medicine）.VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity[J].Acta Pharmaceutica Sinica B,2021,第2期 Keqi Wang¹，Yongyan Chen¹，Shuo Gao¹，Maosi Wang¹，Mengmeng Ge¹，Qian Yang¹，Mingkai Liao¹，Lin Xu¹，Junjie Chen^1,2，Zhiping Zeng^1,2，Haifeng Chen¹，Xiao-kun Zhang^1,2，Ting Lin¹，Hu Zhou^1,2（School of Pharmaceutical Sciences，Fujian Provincial Key Laboratory of Innovative Drug Target Research，Xiamen University；High Throughput Drug Screening Platform，Xiamen University）.Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERa to inhibit RANKL signaling[J].Acta Pharmaceutica Sinica B,2021,第2期 Xinran Cai¹，Ye Feng^1,2，Meishu Xu¹，Chaohui Yu³，Wen Xie^1,4（Center for Pharmacogenetics and Department of Pharmaceutical Sciences，University of Pittsburgh；Department of Endocrinology and Metabolic Disease，the First Affiliated Hospital，Zhejiang University School of Medicine；Department of Gastroenterology，the First Affiliated Hospital，Zhejiang University School of Medicine；Department of Pharmacology and Chemical Biology，University of Pittsburgh）.Gadd45b is required in part for the anti-obesity effect of constitutive androstane receptor(CAR)[J].Acta Pharmaceutica Sinica B,2021,第2期 Hu Zhou¹，Gang He²，Yanbin Sun²，Jingguo Wang²，Haitao Wu²，Ping Jin¹，Zhengbao Zha²（Shenzhen Maternity and Child Healthcare Hospital，Shandong University；School of Food and Biological Engineering，School of Instrument Science and Opto-Electronics Engineering，Hefei University of Technology）.Cryptobiosis-inspired assembly of “AND” logic gate platform for potential tumor-specific drug delivery[J].Acta Pharmaceutica Sinica B,2021,第2期 Qiaozhen Wang¹，Xiaolong Tang²，Ping Dai¹，Chuanxi Wang¹，Weiyang Zhang²，Guodong Chen¹，Kui Hong³，Dan Hu¹，Hao Gao¹，Xinsheng Yao¹（Institute of Traditional Chinese Medicine and Natural Product/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research，College of Pharmacy，Jinan University；Institute of Synthetic Biology，Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences；Key Laboratory of Combinatorial Biosynthesis and Drug Discovery，Ministry of Education，School of Pharmaceutical Sciences，Wuhan University）.A four-protein metabolon assembled by a small peptide protein creates the pentacyclic carbonate ring of aldgamycins[J].Acta Pharmaceutica Sinica B,2021,第2期 Hongxia Duan^1,2，Yanhong Liu^1,2，Zhonggao Gao^1,2，Wei Huang^1,2（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Department of Pharmaceutics，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Recent advances in drug delivery systems for targeting cancer stem cells[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaofei Chen¹，Yunlong Wu²，Chun Chen³，Yanqiu Gu³，Chunyan Zhu²，Suping Wang²，Jiayun Chen²，Lei Zhang¹，Lei Lv⁴，Guoqing Zhang⁴，Yongfang Yuan³，Yifeng Chai¹，Mingshe Zhu⁵，Caisheng Wu²（School of Pharmacy，Naval Medical University；Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology，School of Pharmaceutical Sciences，Xiamen University；Department of Pharmacy，Shanghai Ninth People’s Hospital，Shanghai Jiao Tong University；Department of Pharmacy，Shanghai Eastern Hepatobiliary Surgery Hospital，Naval Medical University；Mass Defect Technologies）.Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening[J].Acta Pharmaceutica Sinica B,2021,第1期 Yanying Zhou¹，Xiaomei Fan²，Tingying Jiao¹，Wenzhou Li²，Panpan Chen¹，Yiming Jiang¹，Jiahong Sun¹，Yixin Chen¹，Pan Chen³，Lihuan Guan¹，Yajie Wen¹，Min Huang¹，Huichang Bi¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Shenzhen Baoan Women’s and Children’s Hospital，Jinan University；Department of Pharmacy，the First Affiliated Hospital of Sun Yat-sen University）.SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation[J].Acta Pharmaceutica Sinica B,2021,第1期 Zhendong Song¹，Meijing Wang²，Yang Ge¹，Xue-Ping Chen¹，Ziyang Xu²，Yang Sun²，Xiao-Feng Xiong¹（Guangdong Key Laboratory of Chiral Molecule and Drug Discovery，School of Pharmaceutical Sciences，Sun Yatsen University；State Key Laboratory of Pharmaceutical Biotechnology，Department of Biotechnology and Pharmaceutical Sciences，School of Life Sciences，Nanjing University）.Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaopan Gao¹，Bo Qin¹，Pu Chen¹，Kaixiang Zhu¹，Pengjiao Hou¹，Justyna Aleksandra Wojdyla²，Meitian Wang²，Sheng Cui¹（NHC Key Laboratory of Systems Biology of Pathogens，Institute of Pathogen Biology，Chinese Academy of Medical Sciences and Peking Union Medical College；The Swiss Light Source (SLS) at the Paul Scherrer Institut）.Crystal structure of SARS-CoV-2 papain-like protease[J].Acta Pharmaceutica Sinica B,2021,第1期 Jiezhou Ye¹，Bo Zeng¹，Meiyan Zhong¹，Hongchun Li²，Lihui Xu³，Junxiang Shu²，Yaofeng Wang¹，Fan Yang¹，Chunsu Zhong¹，Xunjia Ye¹，Xianhui He¹，Dongyun Ouyang¹（Department of Immunobiology，College of Life Science and Technology，Jinan University；Wuzhongpei Memorial Hospital of Shunde；Department of Cell Biology，College of Life Science and Technology，Jinan University）.Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling[J].Acta Pharmaceutica Sinica B,2021,第1期 Hao Zengy，Lingling Wangy，Jiawei Zhang，Ting Pan，Yinghua Yu，Jingxia Lu，Ping Zhou，Hua Yang，Ping Li（State Key Laboratory of Natural Medicines，School of Traditional Chinese Pharmacy，China Pharmaceutical University）.Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity：Therapeutic efficacy of dihydrotanshinone-Ⅰ[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaojie Chen¹，Jiafeng Zou¹，Ke Zhang¹，Jingjing Zhu¹，Yue Zhang¹，Zhihong Zhu¹，Hongyue Zheng²，Fanzhu Li¹，Ji-Gang Piao¹（College of Pharmaceutical Sciences，Zhejiang Chinese Medical University；Libraries of Zhejiang Chinese Medical University，Zhejiang Chinese Medical University）.Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment[J].Acta Pharmaceutica Sinica B,2021,第1期 Zhibin Yan¹，Dan Wang¹，Chunmei An¹，Hongjiao Xu²，Qian Zhao²，Ying Shi²，Nazi Song²，Bochuan Deng¹，Xiaomin Guo¹，Jing Rao¹，Lu Cheng¹，Bangzhi Zhang¹，Lingyun Mou¹，Wenle Yang¹，Xianxing Jiang²，Junqiu Xie¹（Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences &Research Unit of Peptide Science，Chinese Academy of Medical Sciences，2019RU066，Lanzhou University；School of Pharmaceutical Sciences，Sun Yat-sen University）.The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis[J].Acta Pharmaceutica Sinica B,2021,第1期首页上一页 8 9 10 11 下一页尾页共有11页，转到页

期刊文章列表